Keyword search (4,163 papers available)

"Khan S" Authored Publications:

Title Authors PubMed ID
1 The Smart in Smart Cities: A Framework for Image Classification Using Deep Learning Al-Qudah R; Khamayseh Y; Aldwairi M; Khan S; 35746171
ENCS
2 Is subthreshold depression in adolescence clinically relevant? Noyes BK; Munoz DP; Khalid-Khan S; Brietzke E; Booij L; 35429521
PSYCHOLOGY
3 Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice Rawlins LE; Almousa H; Khan S; Collins SC; Milev MP; Leslie J; Saint-Dic D; Khan V; Hincapie AM; Day JO; McGavin L; Rowley C; Harlalka GV; Vancollie VE; Ahmad W; Lelliott CJ; Gul A; Yalcin B; Crosby AH; Sacher M; Baple EL; 35298461
BIOLOGY
4 Maturation of temporal saccade prediction from childhood to adulthood: predictive saccades, reduced pupil size and blink synchronization Calancie OG; Brien DC; Huang J; Coe BC; Booij L; Khalid-Khan S; Munoz DP; 34759032
PSYCHOLOGY
5 Reductions of Anxiety Symptoms, State Anxiety, and Anxious Arousal in Youth Playing the Videogame MindLight Compared to Online Cognitive Behavioral Therapy Tsui TYL; DeFrance K; Khalid-Khan S; Granic I; Hollenstein T; 34403591
PSYCHOLOGY
6 Methodological and clinical challenges associated with biomarkers for psychiatric disease: A scoping review. Kirkpatrick RH; Munoz DP; Khalid-Khan S; Booij L; 33221025
PSYCHOLOGY
7 DNA methylation differences in stress-related genes, functional connectivity and gray matter volume in depressed and healthy adolescents. Chiarella J, Schumann L, Pomares FB, Frodl T, Tozzi L, Nemoda Z, Yu P, Szyf M, Khalid-Khan S, Booij L 32479312
PSYCHOLOGY
8 Are biophenotyes the key to select antinflammatory-responsive individuals with major depression? Brietzke E, Booij L, Wieck A, Soares CN, Roberts N, Khalid-Khan S 31476416
PSYCHOLOGY
9 Eating disorders and substance use in adolescents: How substance users differ from nonsubstance users in an outpatient eating disorders treatment clinic. Kirkpatrick R, Booij L, Vance A, Marshall B, Kanellos-Sutton M, Marchand P, Khalid-Khan S 30638270
PSYCHOLOGY
10 Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients. Vigano AAL, Morais JA, Ciutto L, Rosenthall L, di Tomasso J, Khan S, Olders H, Borod M, Kilgour RD 27793524
HKAP
11 Hypertension management research priorities from patients, caregivers, and healthcare providers: A report from the Hypertension Canada Priority Setting Partnership Group. Khan N, Bacon SL, Khan S, Perlmutter S, Gerlinsky C, Dermer M, Johnson L, Alves F, McLean D, Laupacis A, Pui M, Berg A, Flowitt F, Hypertension Canada Priority Setting Partnership Group 28944609
HKAP

 

Title:Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice
Authors:Rawlins LEAlmousa HKhan SCollins SCMilev MPLeslie JSaint-Dic DKhan VHincapie AMDay JOMcGavin LRowley CHarlalka GVVancollie VEAhmad WLelliott CJGul AYalcin BCrosby AHSacher MBaple EL
Link:pubmed.ncbi.nlm.nih.gov/35298461/
DOI:10.1371/journal.pgen.1010114
Publication:PLoS genetics
Keywords:
PMID:35298461 Category: Date Added:2022-03-18
Dept Affiliation: BIOLOGY
1 RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom.
2 Peninsula Clinical Genetics Service, Royal Devon & Exeter Hospital (Heavitree), Exeter, United Kingdom.
3 Department of Biology, Concordia University, Montreal, Quebec, Canada.
4 Department of Biological Sciences, International Islamic University, Islamabad, Pakistan.
5 Institute of Genetics and Molecular and Cellular Biology, Inserm, Illkirch, France.
6 Inserm, University of Bourgogne Franche-Comté, Dijon, France.
7 Department of Molecular Diagnostics, Rehman Medical Institute, Peshawar, Pakistan.
8 Faculty of Health, University of Plymouth, Plymouth, United Kingdom.
9 University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom.
10 Wellcome Sanger Instit

Description:

The highly evolutionarily conserved transport protein particle (TRAPP) complexes (TRAPP II and III) perform fundamental roles in subcellular trafficking pathways. Here we identified biallelic sequence alterations in TRAPPC10, a component of the TRAPP II complex, in individuals with a severe microcephalic neurodevelopmental disorder. Molecular studies revealed a weakened interaction between mutant TRAPPC10 and its putative adaptor protein TRAPPC2L. Studies of patient lymphoblastoid cells revealed an absence of TRAPPC10 alongside a concomitant absence of TRAPPC9, another key TRAPP II complex component associated with a clinically overlapping neurodevelopmental disorder. The TRAPPC9/10 reduction phenotype was recapitulated in TRAPPC10-/- knockout cells, which also displayed a membrane trafficking defect. Notably, both the reduction in TRAPPC9 levels and the trafficking defect in these cells could be rescued by wild type but not mutant TRAPPC10 gene constructs. Moreover, studies of Trappc10-/- knockout mice revealed neuroanatomical brain defects and microcephaly, paralleling findings seen in the human condition as well as in a Trappc9-/- mouse model. Together these studies confirm biallelic TRAPPC10 gene variants as a cause of human disease and define TRAPP-mediated pathomolecular outcomes of importance to TRAPPC9 and TRAPPC10 mediated neurodevelopmental disorders in humans and mice.




BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University